Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Drug Delivery Technology Market Outlook

The global drug delivery technology market is expected to be valued at US$ 43.9 billion in 2023. Increasing adoption of advanced technology for effectively delivering the drug to the target site is expected to drive overall market growth. The overall demand for drug delivery technology is projected to grow at a CAGR of 12.6% between 2023 and 2033, totaling around 143.5 billion by 2033.

A drug delivery system is a process of administering a therapeutic substance through the common route of administration to achieve a therapeutic effect in humans or animals. Drugs release the active ingredients in the target area that it controls through their formulation in the period.

The most important driving factor for the drug delivery technology market is the increasing demand for effective delivery mechanisms of novel biopharmaceuticals.

Recently, AstraZeneca signed a licensing agreement with Starpharma to use its DEP drug delivery technology, aiming to enhance pharmaceuticals' dosing and efficacy characteristics. AstraZeneca agreed to fund all development and commercialization costs, including ongoing and future collaborative work with Starpharma.

Attribute Details
Market CAGR (2023 to 2033) 12.6%
Market Valuation (2023) US$ 43.9 billion
Market Valuation (2033) US$ 143.5 billion

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Drug Delivery Technology Market: Drivers & Restraints

Growing incidence of chronic diseases such as cardiovascular diseases, diabetes, and cancer, technological advancement, innovation, the growing focus on pediatric and geriatric patients, changes in lifestyle due to growing urbanization, and the increasing demand for minimally invasive surgeries are the most important driving factors in drug delivery technology market. Since the growth of the biopharmaceutical market is fast, the demand for the drug delivery technology market has increased.

With so many advantages and splendid features of drug delivery technology, it has a few disadvantages too. Side effects related to drugs, patent expiry, and regulatory hurdles are key barriers to drug delivery technology.

Which Drivers Underpin Drug Delivery Technology Industry Expansion?

Rising Prevalence of Chronic Diseases & Surplus Investments in R&D to Act as Primary Growth Drivers

Growing incidence of chronic diseases such as cardiovascular diseases, diabetes, and cancer, technological advancement, innovation, the growing focus on pediatric and geriatric patients, changes in lifestyle due to growing urbanization, and the increasing demand for minimally invasive surgeries, are the most important driving factors in the global market. Since the growth of the biopharmaceutical market is fast, the demand for the drug delivery technology market has increased.

Swelling demand for novel drug delivery devices is expected to advance R&D in the field. Key market players perpetually engage in strategic alliances to develop advanced technology for various applications.

In January 2021, AstraZeneca collaborated with Aptamer Group, a biotechnology company, to explore its technology to develop a novel drug-delivery device for a kidney. In addition, the increasing adoption of drug-delivery devices in home-care settings is snowballing the accessibility of these devices for patients.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Challenges Faced by the Drug Delivery Technology Industry?

Uncontrolled Intake of Medicine May Lead to Certain Side Effects Likely to Impede Market Growth.

Despite the advantages and advancements of these drug delivery devices, certain challenges are expected to hinder market growth. The major challenge faced with this drug delivery device is its inefficiency in delivering poorly soluble drugs.

Furthermore, other bioavailability hurdles of poorly soluble drugs are also expected to impact market growth. In addition, these drug delivery devices may release uncontrolled drugs on the infection site, which can later lead to other side effects such as infections and allergies.

Drug Delivery Technology Demand Analysis (2018 to 2022) Vs Market Outlook (2023 to 2033)

The global demand for drug delivery technology secured a CAGR of 8.6% between 2018 and 2022. The market captured a valuation of US$ 26 billion in 2018 and US$ 39.3 billion in 2022.

The drug delivery technology market has grown substantially at a healthy CAGR due to the growing incidence of chronic diseases and lifestyle changes. With rapid technological advancement and innovation, the drug delivery technology market is expected to grow globally.

In addition, the increasing prevalence of chronic diseases in regions like North America and Europe has boosted the demand for drug delivery technology. According to Rand.org, almost 60 percent of American adults with at least one chronic condition 42 percent have more than one.

They account for hundreds of billions of dollars in healthcare spending every year. Owing to these factors, the market for drug delivery technology is projected to experience exceptional growth over the forecast period.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-Wise Insights

By Route of Administration, which Drug Delivery Technology Category is estimated to remain Prominent?

Based on the route of administration, the oral route of administration subtype captures the highest share in 2023. It is expected to be the fastest-growing segment of the Drug Delivery Technology market during the forecast period.

The oral drug delivery system comprises extensive dosage forms, including tablets, capsules, syrups, solutions, and suspensions. This segment also contains drug delivery products such as films and tablets. The oral route is the preferred route of administration regarding safety, ease of use, cost, and drug stability.

Inhalation drug delivery systems are ideal for pulmonary conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD). Aspects such as the growing prevalence of respiratory diseases and the technological development of devices used for inhalation delivery, such as nebulizers and inhalers, are anticipated to propel the growth of this segment.

The injectable route of administration is likely to expand at the fastest growth rate throughout the forecast period. Progressions in injectable drug delivery systems, such as the advent of prefilled syringes and pen injectors, have augmented the demand in the past two to three years. Additionally, developing materials for syringes, such as polymers, which are inert to most chemicals, stimulates market growth.

Region-Wise Insights

Countries Forecast Share Between 2023 to 2033
United States 28.6%
Germany 5.5%
Japan 5.3%
Countries Forecast CAGR Between 2023 to 2033
Australia 7.7%
China 10.1%
India 9.5%
United Kingdom 8.8%

North America Holds a Significant Position in the Global Drug Delivery Technology Market?

Rising Awareness Regarding the Novel Advancements & Presence of Prominent Players to Put Region at the Forefront

Regarding regional platforms, North America holds a significant market share in the market. The region is expected to surge at over 33.6% share in 2023. It is projected to maintain its lead over the forecast period due to its preference for printing by thermal label manufacturers. The United States & Canada account for most of the regional revenue contribution.

This market growth is attributed to prominent regional players and the growing adoption of drug-delivery devices. Besides, rising awareness in the region regarding the advantages of drug delivery devices is also likely to boost the market growth in the region.

In addition, growing product approval in countries such as the United States is also projected to contribute to market growth. In March 2019, Aptar Pharma received USA FDA approval for a nasal drug delivery device.

The increasing burden of chronic diseases such as cancer, diabetes, and cardiac disorders is aiding the market growth. According to the American Diabetes Association (ADA), 34.2 million Americans had diabetes in 2020, of which 26.8 million were diagnosed and 7.3 million were undiagnosed. Consequently, an increasing number of diagnosed diabetes cases is anticipated to contribute toward adopting drug-delivery devices for diabetes.

How is the Growth of the European Drug Delivery Technology Market unfolding?

Availability of Exceptional Healthcare Infrastructure to Boost Regional Revenue Share

According to Future Market Insights, Europe is expected to provide immense growth opportunities for Drug Delivery Technology and reach the highest share of 29.3% in 2023. This market growth is attributed to growing research and developmental activities and the presence of key pharmaceutical companies in the region.

With the significant surge in patients suffering from chronic diseases such as cancer, diabetes, and COPD, the regional market is subject to tread along a stellar growth track over the coming years.

In Nov 2021, Baxter International Inc., a global leader in sterile medication production and delivery, announced an approximately US$100 million expansion of its sterile fill/finish manufacturing facility in Halle/Westfalen, Germany. Surplus investments by key players in research facilities have propelled the market growth for drug delivery technology.

How is estimated to Asia Pacific Bolster the Demand for Drug Delivery Technology?

Expanding Geriatric Population one of the Significant Causes of the Development of Drug Delivery Technology

As per the recent analysis by Future Market Insights, Asia Pacific is anticipated to be the highest-growing region over the forecast period. A large patient pool in countries like Japan, China, and India is also leading to the adoption of drug-delivery devices by several end-users. In addition, in Japan, distinctive drug delivery devices are being introduced for delivering specific types of drugs.

In December 2019, the YpsoMate autoinjector was launched in the Japanese market to accurately deliver Teribone drug. Thus, the growing adoption of advanced drug delivery devices in the region is expected to boost market growth during the forecast period.

Also, regional players are doing mergers and acquisitions to expand their product portfolio and increase market reach. For instance, Pfizer Inc. and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based therapeutics, today announced they have entered into a Development and Option agreement under which Pfizer is estimated to have the option to license, on a non-exclusive basis, Acuitas’ LNP technology for up to 10 targets for vaccine or therapeutic development.

The Startup Ecosystem

How are key players Opening Frontiers for Future Growth?

Many prominent market players in the global market are working hand-in-hand to provide the best-in-class Drug Delivery Technology for enhancing the global analytics arena.

However, many global startups in the global market are stepping forward to match the requirements of the Drug Delivery Technology domain.

  • Founded in 2001, CROSSJECT developed a needle-free injection platform called Zeneo, designed to improve patient safety, provide comfort, and enable a better observance of treatments. The product is a pre-fillable, needle-free injection system that is claimed to deliver drugs intradermally, subcutaneously, and intramuscularly. As of Jan 2017, the company is developing a portfolio of products combining well-known drugs with an innovative injection mode, particularly adapted to emergencies and most chronic treatments, with a device adaptable to many specific situations. The company has recorded annual revenues of US$ 40 million and is based out of Dijon (France).
  • Founded in 2013, AFYX Therapeutics develops drug patches for treating mucosal diseases. It has developed Rivelin, a self-adhesive drug patch designed to deliver uniform doses of therapy to the mucosal lining. The company's lead product candidate Rivelin-CLO is used against oral lichen planus. The startup is located in Copenhagen (Denmark) and has gathered overall funding of US$ 33 Billion.
  • Founded in 2013, S.C. Pharmaceuticals is a provider of a subcutaneous drug delivery device for treating bacterial infections and heart failure. The company has developed a device called sc2Wear Pump that facilitates subcutaneous drug administration over durations, rates, and volumes that can be tailored to specific drugs. The pipeline includes Furosemide for heart failure, Ceftriaxone, and Ertapenem to treat bacterial infections. The company is based out of Lexington, Massachusetts, United States, and received nearly US$ 20 Million in overall funding.

Competitive Landscape

What are the Leading Players in the Drug Delivery Technology Market Up to?

  • In December 2021, Johnson & Johnson announced the acquisition of TARIS Biomedical LLC (TARIS), a privately-owned biotechnology company specializing in developing a novel drug delivery technology for treating bladder diseases, including cancer. The company's lead clinical-stage product, TAR-200, uses the proprietary TARIS System, which features a silicone-based drug delivery device that allows for the continuous release of medication into the bladder.
  • In May 2021, 3M announced that it had completed the sale of substantially all of its drug delivery business to an affiliate of Altaris Capital Partners, LLC., for approximately US$ 650 Billion in total consideration, including cash, interest-bearing security, and a 17 percent non-controlling interest in the new company, Kindeva Drug Delivery, that is estimated to operate the business.
  • In August 2022, Merck tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that is estimated to enable it to evaluate candidates based on a dendrimer drug delivery platform.

Scope of Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ billion for Value
Key Countries Covered United States, United Kingdom, Japan, India, China, Australia, Germany
Key Segments Covered
  • Route of Administration
  • End User
  • Region
Key Companies Profiled
  • Johnson and Johnson Pvt. Ltd
  • 3M
  • Novartis AG
  • Pfizer Inc.
  • GlaxoSmithKline PLC
  • Merck & Co. Inc.
  • Antares Pharma
  • Generex Biotechnology
  • Sivida Corporation
  • Alkermes
  • Aradigm Corp.
  • Vectura Group Plc.
  • NanoPass Technologies Ltd.
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Drug Delivery Technology Market by Segmentation

By Route of Administration:

  • Oral Route
  • Parenteral Route
  • Intramuscular
  • Intravenous
  • Intra-arterial
  • Subcutaneous route
  • Transdermal Route
  • Inhalation Route
  • Nasal Drug Delivery

By End User:

  • Hospitals
  • Clinics
  • Diagnostic Centres
  • Home care settings
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa (MEA)

Frequently Asked Questions

How Big is the Drug Delivery Technology Market?

The global drug delivery technology market valuation is US$ 43.9 billion in 2023.

What is the Future Outlook for the Drug Delivery Technology Market?

The global market is estimated to exceed US$ 143.5 billion by 2033, registering a 12.6% CAGR over the forecast period.

How is the Market in India Evolving?

The market in India is experiencing robust growth, with a projected 9.5% CAGR through 2033.

What are the Different Types of Drug Delivery Technology in the Market?

Different types of drug delivery technologies in the market include oral drug delivery, injectable drug delivery, transdermal patches, and others.

What are the Recent Advancements in Drug Delivery Technology?

Recent advancements encompass nanotechnology-based carriers, targeted drug delivery, and smart drug delivery systems.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033

        5.3.1. Oral Route

        5.3.2. Parenteral Route

        5.3.3. Intramuscular

        5.3.4. Intravenous

        5.3.5. Intra-arterial

        5.3.6. Subcutaneous route

        5.3.7. Transdermal Route

        5.3.8. Inhalation Route

        5.3.9. Nasal Drug Delivery

    5.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Route of Administration, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        6.3.1. Hospitals

        6.3.2. Clinics

        6.3.3. Diagnostic Centres

        6.3.4. Home care settings

        6.3.5. Others

    6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. The USA

            8.2.1.2. Canada

        8.2.2. By Route of Administration

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Route of Administration

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Route of Administration

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Route of Administration

        9.3.3. By End User

    9.4. Key Takeaways

10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. United Kingdom

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Route of Administration

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Route of Administration

        10.3.3. By End User

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Route of Administration

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Route of Administration

        11.3.3. By End User

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Route of Administration

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Route of Administration

        12.3.3. By End User

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Route of Administration

        13.2.3. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Route of Administration

        13.3.3. By End User

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Route of Administration

        14.2.3. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Route of Administration

        14.3.3. By End User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Route of Administration

            15.1.2.2. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Route of Administration

            15.2.2.2. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Route of Administration

            15.3.2.2. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Route of Administration

            15.4.2.2. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Route of Administration

            15.5.2.2. By End User

    15.6. United Kingdom

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Route of Administration

            15.6.2.2. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Route of Administration

            15.7.2.2. By End User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Route of Administration

            15.8.2.2. By End User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Route of Administration

            15.9.2.2. By End User

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Route of Administration

            15.10.2.2. By End User

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Route of Administration

            15.11.2.2. By End User

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Route of Administration

            15.12.2.2. By End User

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Route of Administration

            15.13.2.2. By End User

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Route of Administration

            15.14.2.2. By End User

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Route of Administration

            15.15.2.2. By End User

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Route of Administration

            15.16.2.2. By End User

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Route of Administration

            15.17.2.2. By End User

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Route of Administration

            15.18.2.2. By End User

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Route of Administration

            15.19.2.2. By End User

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Route of Administration

            15.20.2.2. By End User

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Route of Administration

            15.21.2.2. By End User

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Route of Administration

            15.22.2.2. By End User

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Route of Administration

            15.23.2.2. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Route of Administration

        16.3.3. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Johnson and Johnson Pvt. Ltd

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. 3M

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Novartis AG

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Pfizer Inc.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. GlaxoSmithKline PLC

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Merck & Co. Inc.

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Antares Pharma

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Generex Biotechnology

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Sivida Corporation

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Alkermes

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 4: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 6: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 8: Latin America Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 11: Western Europe Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 12: Western Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Eastern Europe Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 15: Eastern Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 20: East Asia Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 21: East Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 24: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2018 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by End User, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 7: Global Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 8: Global Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 9: Global Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 10: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 13: Global Market Attractiveness by Route of Administration, 2023 to 2033

Figure 14: Global Market Attractiveness by End User, 2023 to 2033

Figure 15: Global Market Attractiveness by Region, 2023 to 2033

Figure 16: North America Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 17: North America Market Value (US$ Million) by End User, 2023 to 2033

Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 22: North America Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 23: North America Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 24: North America Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 28: North America Market Attractiveness by Route of Administration, 2023 to 2033

Figure 29: North America Market Attractiveness by End User, 2023 to 2033

Figure 30: North America Market Attractiveness by Country, 2023 to 2033

Figure 31: Latin America Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 32: Latin America Market Value (US$ Million) by End User, 2023 to 2033

Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 37: Latin America Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 40: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 43: Latin America Market Attractiveness by Route of Administration, 2023 to 2033

Figure 44: Latin America Market Attractiveness by End User, 2023 to 2033

Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 46: Western Europe Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 47: Western Europe Market Value (US$ Million) by End User, 2023 to 2033

Figure 48: Western Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 52: Western Europe Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 55: Western Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 56: Western Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 58: Western Europe Market Attractiveness by Route of Administration, 2023 to 2033

Figure 59: Western Europe Market Attractiveness by End User, 2023 to 2033

Figure 60: Western Europe Market Attractiveness by Country, 2023 to 2033

Figure 61: Eastern Europe Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 62: Eastern Europe Market Value (US$ Million) by End User, 2023 to 2033

Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 70: Eastern Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 73: Eastern Europe Market Attractiveness by Route of Administration, 2023 to 2033

Figure 74: Eastern Europe Market Attractiveness by End User, 2023 to 2033

Figure 75: Eastern Europe Market Attractiveness by Country, 2023 to 2033

Figure 76: South Asia and Pacific Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 77: South Asia and Pacific Market Value (US$ Million) by End User, 2023 to 2033

Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033

Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 88: South Asia and Pacific Market Attractiveness by Route of Administration, 2023 to 2033

Figure 89: South Asia and Pacific Market Attractiveness by End User, 2023 to 2033

Figure 90: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033

Figure 91: East Asia Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 92: East Asia Market Value (US$ Million) by End User, 2023 to 2033

Figure 93: East Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 97: East Asia Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 98: East Asia Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 100: East Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 101: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 102: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 103: East Asia Market Attractiveness by Route of Administration, 2023 to 2033

Figure 104: East Asia Market Attractiveness by End User, 2023 to 2033

Figure 105: East Asia Market Attractiveness by Country, 2023 to 2033

Figure 106: Middle East and Africa Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 107: Middle East and Africa Market Value (US$ Million) by End User, 2023 to 2033

Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033

Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 118: Middle East and Africa Market Attractiveness by Route of Administration, 2023 to 2033

Figure 119: Middle East and Africa Market Attractiveness by End User, 2023 to 2033

Figure 120: Middle East and Africa Market Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Pharmaceutical Drug Delivery Market

Published : January 2023

Healthcare

Injectable Drug Delivery Market

Published : December 2022

Explore Healthcare Insights

View Reports

Drug Delivery Technology Market